Abstract

The aim of the study was to investigate the expression of insulin-like growth factor binding protein 6 (IGFBP-6) in cancer tissues in relation with clinical and morphological parameters, IGF-IR expression, serum adiponectin level and its receptors (AdipoR1, AdipoR2) in patients with colorectal cancer.Material and Methods. The study included 31 patients with colorectal cancer (T2–4N0–2M0). Serum adiponectin level, AdipoR1 and AdipoR2 expression were evaluated with ELISA. IGF-IR expression was evaluated in tumor tissue by flow cytometry. IGFBP-6 expression was evaluated with Western blotting.Results. The dependence of IGFBP-6 expression, AdipoR1, AdipoR2 on tumor invasion and lymph nodes status were revealed. There is no association IGFBP-6 expression, AdipoR1 and AdipoR2 expression and serum adiponectin level with metabolic syndrome. The revealed positive relationships between IGFBP-6 expression and AdipoR1 expression, between IGFBP-6 expression and AdipoR2 expression, between IGF-IR and AdipoR1 expression show cross-talk between IGF-IR and adiponectin/AdipoR1 pathways in colorectal carcinomas.

Highlights

  • AdipoR1 and AdipoR2 expression were evaluated with ELISA

  • Insulin-like growth factor (IGF)-IR expression was evaluated in tumor tissue by flow cytometry

  • insulin-like growth factor binding protein 6 (IGFBP-6) expression was evaluated with Western blotting

Read more

Summary

Материал и методы

 èññëåäîâàíèå áûë âêëþ÷åí 31 ïàöèåíò (15 ìóæ÷èí è 16 æåíùèí) ñ êîëîðåêòàëüíûì ðàêîì ñ ðàñïðîñòðàíåííîñòüþ îïóõîëåâîãî ïðîöåññà T2–4N0–2M0 (òàáë. 1).  èññëåäîâàíèå áûë âêëþ÷åí 31 ïàöèåíò (15 ìóæ÷èí è 16 æåíùèí) ñ êîëîðåêòàëüíûì ðàêîì ñ ðàñïðîñòðàíåííîñòüþ îïóõîëåâîãî ïðîöåññà T2–4N0–2M0 Êðèòåðèÿìè âêëþ÷åíèÿ â ãðóïïó ñ ÌÑ ñ ó÷åòîì ðåêîìåíäàöèé International Diabetes Federation (2005) ÿâëÿëñÿ àáäîìèíàëüíûé òèï îæèðåíèÿ (îêðóæíîñòü òàëèè áîëåå 94 ñì ó ìóæ÷èí è áîëåå 80 ñì – ó æåíùèí – äëÿ ïðåäñòàâèòåëåé åâðîïåîèäíîé ðàñû) â ñî÷åòàíèè, êàê ìèíèìóì, ñ äâóìÿ èç 4 äîïîëíèòåëüíûõ êðèòåðèåâ: ïîâûøåíèå óðîâíÿ òðèãëèöåðèäîâ áîëåå 1,7 ììîëü/ë èëè ïðîâîäèìîå ðàíåå ëå÷åíèå äèñëèïèäåìèè; ñíèæåíèå óðîâíÿ ëèïîïðîòåèäîâ âûñîêîé. Îöåíêà ñîñòîÿíèÿ óãëåâîäíîãî è ëèïèäíîãî îáìåíà âêëþ÷àëà îïðåäåëåíèå óðîâíÿ ãëþêîçû ãëþêîçîîêñèäàçíûì ìåòîäîì, îáùåãî õîëåñòåðèíà, ËÏÂÏ è òðèãëèöåðèäîâ ñ èñïîëüçîâàíèåì ðåàêòèâîâ ôèðìû Human (Ãåðìàíèÿ) è ThermoScientific (Ôèíëÿíäèÿ). Àíàëèç óðîâíÿ ýêñïðåññèè IGF-IR ïðîâîäèëñÿ ìåòîäîì ïðîòî÷íîé öèòîìåòðèè íà öèòîôëþîðèìåòðå FACS Canto II (Becton Dickinson (BD), ÑØÀ). Îöåíêà ðåçóëüòàòîâ ïðîâîäèëàñü ñ ïîìîùüþ ïðîãðàììû FACS Diva 6.1, ðåçóëüòàòû ïðåäñòàâëåíû êàê ïðîöåíò öèòîêåðàòèí 20-ïîçèòèâíûõ êëåòîê, ýêñïðåññèðóþùèé IGF-IR. Êîððåëÿöèîííûé àíàëèç äàííûõ âûïîëíåí ñ ðàñ÷åòîì êîýôôèöèåíòîâ êîððåëÿöèè Ñïèðìåíà R, àíàëèçèðîâàëèñü òîëüêî çíà÷èìûå êîððåëÿöèîííûå ñâÿçè (p < 0,05)

Результаты и обсуждение
Material and Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call